1CM
SPPI

1492 Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

1492 Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-23,383
Closed -$162K – 151
2014
Q4 		$162K Hold
23,383
– – 0.1% 114
2014
Q3 		$190K Sell
23,383
-985
-4% -$7.71K 0.11% 116
2014
Q2 		$198K Buy
24,368
+673
+3% +$5.11K 0.1% 118
2014
Q1 		$186K Buy
23,695
+3,300
+16% +$27.9K 0.09% 123
2013
Q4 		$180K Buy
+20,395
New +$182K 0.1% 127

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1492 Capital Management's SPPI Position: Q1 2015 in Review

1492 Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2015, closing a stake of 23,383 shares — an estimated $162K sold.

1492 Capital Management first reported a position in SPPI in Q4 2013 and held it in 5 quarters. The position peaked at $198K in Q2 2014. 137 funds tracked by Wall St. Rank hold SPPI as of Q1 2015.

  • 1492 Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • 1492 Capital Management sold 23,383 Spectrum Pharmaceuticals Inc shares in Q1 2015, an estimated $162K.
  • 1492 Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2013 and held it in 5 quarters.
  • 1492 Capital Management's Spectrum Pharmaceuticals Inc position peaked at $198K in Q2 2014.
  • 137 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2015.

Based on 1492 Capital Management's 13F filing for Q1 2015, filed 13 May 2015.